Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Varga

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Gut Microbes|December 31, 2020
Immunostimulatory membrane proteins potentiate <i>H. pylori</i>-induced carcinogenesis by enabling CagA translocationMatthew G Varga, Cecily R Wood, Julia Butt, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohortTyler J Nielsen, Matthew G Varga, Catherine T Cronister, et al.
Clinical Lung Cancer|December 1, 2024
Brief Report: Methylation-Based ctDNA Serial Monitoring Correlates With Immunotherapy Response in NSCLCAngela Hsiao, Brian Woodward, Patrick Ye, et al.
Mbio|May 30, 2019
Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic PhenotypeJennifer M Noto, Joseph P Zackular, Matthew G Varga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2017
<i>Helicobacter pylori</i> Blood Biomarkers and Gastric Cancer Survival in ChinaMatthew G Varga, Tianyi Wang, Hui Cai, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 14, 2015
miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathwayIsmael Riquelme, Oscar Tapia, Pamela Leal, et al.
Journal of Translational Medicine|August 16, 2022
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patientsRobert S Seitz, Michael E Hurwitz, Tyler J Nielsen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 4, 2016
TLR9 activation suppresses inflammation in response to Helicobacter pylori infectionMatthew G Varga, M Blanca Piazuelo, Judith Romero-Gallo, et al.
Clinical Lung Cancer|December 23, 2022
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer StudyDavid L Saltman, Matthew G Varga, Tyler J Nielsen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 28, 2019
Smoking, <i>Helicobacter Pylori</i> Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and KoreaJulia Butt, Matthew G Varga, Tianyi Wang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Gut Microbes|December 31, 2020
Immunostimulatory membrane proteins potentiate <i>H. pylori</i>-induced carcinogenesis by enabling CagA translocationMatthew G Varga, Cecily R Wood, Julia Butt, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohortTyler J Nielsen, Matthew G Varga, Catherine T Cronister, et al.
Clinical Lung Cancer|December 1, 2024
Brief Report: Methylation-Based ctDNA Serial Monitoring Correlates With Immunotherapy Response in NSCLCAngela Hsiao, Brian Woodward, Patrick Ye, et al.
Mbio|May 30, 2019
Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic PhenotypeJennifer M Noto, Joseph P Zackular, Matthew G Varga, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2017
<i>Helicobacter pylori</i> Blood Biomarkers and Gastric Cancer Survival in ChinaMatthew G Varga, Tianyi Wang, Hui Cai, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 14, 2015
miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathwayIsmael Riquelme, Oscar Tapia, Pamela Leal, et al.
Journal of Translational Medicine|August 16, 2022
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patientsRobert S Seitz, Michael E Hurwitz, Tyler J Nielsen, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 4, 2016
TLR9 activation suppresses inflammation in response to Helicobacter pylori infectionMatthew G Varga, M Blanca Piazuelo, Judith Romero-Gallo, et al.
Clinical Lung Cancer|December 23, 2022
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer StudyDavid L Saltman, Matthew G Varga, Tyler J Nielsen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 28, 2019
Smoking, <i>Helicobacter Pylori</i> Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and KoreaJulia Butt, Matthew G Varga, Tianyi Wang, et al.
Pageof 3